Biological Implants-Global Market Status and Trend Report 2013-2023
Report Summary
Biological Implants-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biological Implants industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Biological Implants 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biological Implants worldwide, with company and product introduction, position in the Biological Implants market
Market status and development trend of Biological Implants by types and applications
Cost and profit status of Biological Implants, and marketing status
Market growth drivers and challenges
The report segments the global Biological Implants market as:
Global Biological Implants Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Biological Implants Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Autografts
Allografts
Xenografts
Global Biological Implants Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiovascular Implants
Orthopedic Implants
Dental Implants
Other
Global Biological Implants Market: Manufacturers Segment Analysis (Company and Product introduction, Biological Implants Sales Volume, Revenue, Price and Gross Margin):
Integra LifeSciences Corporation
NuVasive, Inc
Edward LifeSciences Corporation
Stryker Corporation
LifeCell corporation
Medtronic
RTI Surgical, Inc
BioPolymer GmbH & Co. KG
Johnson & Johnson
Baxter International, Inc.
Vericel Corporation
Alphatec Spine, Inc
CryoLife
Maxigen Biotech, Inc.
IOP Ophthalmic Products, Inc.
CONMED
Allergan Plc
BioTissue
Auto Tissue Berlin GmbH
MiMedx Group, Inc.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biological Implants-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biological Implants industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Biological Implants 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Biological Implants worldwide, with company and product introduction, position in the Biological Implants market
Market status and development trend of Biological Implants by types and applications
Cost and profit status of Biological Implants, and marketing status
Market growth drivers and challenges
The report segments the global Biological Implants market as:
Global Biological Implants Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Biological Implants Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Autografts
Allografts
Xenografts
Global Biological Implants Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiovascular Implants
Orthopedic Implants
Dental Implants
Other
Global Biological Implants Market: Manufacturers Segment Analysis (Company and Product introduction, Biological Implants Sales Volume, Revenue, Price and Gross Margin):
Integra LifeSciences Corporation
NuVasive, Inc
Edward LifeSciences Corporation
Stryker Corporation
LifeCell corporation
Medtronic
RTI Surgical, Inc
BioPolymer GmbH & Co. KG
Johnson & Johnson
Baxter International, Inc.
Vericel Corporation
Alphatec Spine, Inc
CryoLife
Maxigen Biotech, Inc.
IOP Ophthalmic Products, Inc.
CONMED
Allergan Plc
BioTissue
Auto Tissue Berlin GmbH
MiMedx Group, Inc.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOLOGICAL IMPLANTS
1.1 Definition of Biological Implants in This Report
1.2 Commercial Types of Biological Implants
1.2.1 Autografts
1.2.2 Allografts
1.2.3 Xenografts
1.3 Downstream Application of Biological Implants
1.3.1 Cardiovascular Implants
1.3.2 Orthopedic Implants
1.3.3 Dental Implants
1.3.4 Other
1.4 Development History of Biological Implants
1.5 Market Status and Trend of Biological Implants 2013-2023
1.5.1 Global Biological Implants Market Status and Trend 2013-2023
1.5.2 Regional Biological Implants Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Biological Implants 2013-2017
2.2 Production Market of Biological Implants by Regions
2.2.1 Production Volume of Biological Implants by Regions
2.2.2 Production Value of Biological Implants by Regions
2.3 Demand Market of Biological Implants by Regions
2.4 Production and Demand Status of Biological Implants by Regions
2.4.1 Production and Demand Status of Biological Implants by Regions 2013-2017
2.4.2 Import and Export Status of Biological Implants by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Biological Implants by Types
3.2 Production Value of Biological Implants by Types
3.3 Market Forecast of Biological Implants by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biological Implants by Downstream Industry
4.2 Market Forecast of Biological Implants by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOLOGICAL IMPLANTS
5.1 Global Economy Situation and Trend Overview
5.2 Biological Implants Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOLOGICAL IMPLANTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Biological Implants by Major Manufacturers
6.2 Production Value of Biological Implants by Major Manufacturers
6.3 Basic Information of Biological Implants by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Biological Implants Major Manufacturer
6.3.2 Employees and Revenue Level of Biological Implants Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOLOGICAL IMPLANTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Integra LifeSciences Corporation
7.1.1 Company profile
7.1.2 Representative Biological Implants Product
7.1.3 Biological Implants Sales, Revenue, Price and Gross Margin of Integra LifeSciences Corporation
7.2 NuVasive, Inc
7.2.1 Company profile
7.2.2 Representative Biological Implants Product
7.2.3 Biological Implants Sales, Revenue, Price and Gross Margin of NuVasive, Inc
7.3 Edward LifeSciences Corporation
7.3.1 Company profile
7.3.2 Representative Biological Implants Product
7.3.3 Biological Implants Sales, Revenue, Price and Gross Margin of Edward LifeSciences Corporation
7.4 Stryker Corporation
7.4.1 Company profile
7.4.2 Representative Biological Implants Product
7.4.3 Biological Implants Sales, Revenue, Price and Gross Margin of Stryker Corporation
7.5 LifeCell corporation
7.5.1 Company profile
7.5.2 Representative Biological Implants Product
7.5.3 Biological Implants Sales, Revenue, Price and Gross Margin of LifeCell corporation
7.6 Medtronic
7.6.1 Company profile
7.6.2 Representative Biological Implants Product
7.6.3 Biological Implants Sales, Revenue, Price and Gross Margin of Medtronic
7.7 RTI Surgical, Inc
7.7.1 Company profile
7.7.2 Representative Biological Implants Product
7.7.3 Biological Implants Sales, Revenue, Price and Gross Margin of RTI Surgical, Inc
7.8 BioPolymer GmbH & Co. KG
7.8.1 Company profile
7.8.2 Representative Biological Implants Product
7.8.3 Biological Implants Sales, Revenue, Price and Gross Margin of BioPolymer GmbH & Co. KG
7.9 Johnson & Johnson
7.9.1 Company profile
7.9.2 Representative Biological Implants Product
7.9.3 Biological Implants Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.10 Baxter International, Inc.
7.10.1 Company profile
7.10.2 Representative Biological Implants Product
7.10.3 Biological Implants Sales, Revenue, Price and Gross Margin of Baxter International, Inc.
7.11 Vericel Corporation
7.11.1 Company profile
7.11.2 Representative Biological Implants Product
7.11.3 Biological Implants Sales, Revenue, Price and Gross Margin of Vericel Corporation
7.12 Alphatec Spine, Inc
7.12.1 Company profile
7.12.2 Representative Biological Implants Product
7.12.3 Biological Implants Sales, Revenue, Price and Gross Margin of Alphatec Spine, Inc
7.13 CryoLife
7.13.1 Company profile
7.13.2 Representative Biological Implants Product
7.13.3 Biological Implants Sales, Revenue, Price and Gross Margin of CryoLife
7.14 Maxigen Biotech, Inc.
7.14.1 Company profile
7.14.2 Representative Biological Implants Product
7.14.3 Biological Implants Sales, Revenue, Price and Gross Margin of Maxigen Biotech, Inc.
7.15 IOP Ophthalmic Products, Inc.
7.15.1 Company profile
7.15.2 Representative Biological Implants Product
7.15.3 Biological Implants Sales, Revenue, Price and Gross Margin of IOP Ophthalmic Products, Inc.
7.16 CONMED
7.17 Allergan Plc
7.18 BioTissue
7.19 Auto Tissue Berlin GmbH
7.20 MiMedx Group, Inc.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOLOGICAL IMPLANTS
8.1 Industry Chain of Biological Implants
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOLOGICAL IMPLANTS
9.1 Cost Structure Analysis of Biological Implants
9.2 Raw Materials Cost Analysis of Biological Implants
9.3 Labor Cost Analysis of Biological Implants
9.4 Manufacturing Expenses Analysis of Biological Implants
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOLOGICAL IMPLANTS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Biological Implants in This Report
1.2 Commercial Types of Biological Implants
1.2.1 Autografts
1.2.2 Allografts
1.2.3 Xenografts
1.3 Downstream Application of Biological Implants
1.3.1 Cardiovascular Implants
1.3.2 Orthopedic Implants
1.3.3 Dental Implants
1.3.4 Other
1.4 Development History of Biological Implants
1.5 Market Status and Trend of Biological Implants 2013-2023
1.5.1 Global Biological Implants Market Status and Trend 2013-2023
1.5.2 Regional Biological Implants Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Biological Implants 2013-2017
2.2 Production Market of Biological Implants by Regions
2.2.1 Production Volume of Biological Implants by Regions
2.2.2 Production Value of Biological Implants by Regions
2.3 Demand Market of Biological Implants by Regions
2.4 Production and Demand Status of Biological Implants by Regions
2.4.1 Production and Demand Status of Biological Implants by Regions 2013-2017
2.4.2 Import and Export Status of Biological Implants by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Biological Implants by Types
3.2 Production Value of Biological Implants by Types
3.3 Market Forecast of Biological Implants by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biological Implants by Downstream Industry
4.2 Market Forecast of Biological Implants by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOLOGICAL IMPLANTS
5.1 Global Economy Situation and Trend Overview
5.2 Biological Implants Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOLOGICAL IMPLANTS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Biological Implants by Major Manufacturers
6.2 Production Value of Biological Implants by Major Manufacturers
6.3 Basic Information of Biological Implants by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Biological Implants Major Manufacturer
6.3.2 Employees and Revenue Level of Biological Implants Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOLOGICAL IMPLANTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Integra LifeSciences Corporation
7.1.1 Company profile
7.1.2 Representative Biological Implants Product
7.1.3 Biological Implants Sales, Revenue, Price and Gross Margin of Integra LifeSciences Corporation
7.2 NuVasive, Inc
7.2.1 Company profile
7.2.2 Representative Biological Implants Product
7.2.3 Biological Implants Sales, Revenue, Price and Gross Margin of NuVasive, Inc
7.3 Edward LifeSciences Corporation
7.3.1 Company profile
7.3.2 Representative Biological Implants Product
7.3.3 Biological Implants Sales, Revenue, Price and Gross Margin of Edward LifeSciences Corporation
7.4 Stryker Corporation
7.4.1 Company profile
7.4.2 Representative Biological Implants Product
7.4.3 Biological Implants Sales, Revenue, Price and Gross Margin of Stryker Corporation
7.5 LifeCell corporation
7.5.1 Company profile
7.5.2 Representative Biological Implants Product
7.5.3 Biological Implants Sales, Revenue, Price and Gross Margin of LifeCell corporation
7.6 Medtronic
7.6.1 Company profile
7.6.2 Representative Biological Implants Product
7.6.3 Biological Implants Sales, Revenue, Price and Gross Margin of Medtronic
7.7 RTI Surgical, Inc
7.7.1 Company profile
7.7.2 Representative Biological Implants Product
7.7.3 Biological Implants Sales, Revenue, Price and Gross Margin of RTI Surgical, Inc
7.8 BioPolymer GmbH & Co. KG
7.8.1 Company profile
7.8.2 Representative Biological Implants Product
7.8.3 Biological Implants Sales, Revenue, Price and Gross Margin of BioPolymer GmbH & Co. KG
7.9 Johnson & Johnson
7.9.1 Company profile
7.9.2 Representative Biological Implants Product
7.9.3 Biological Implants Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.10 Baxter International, Inc.
7.10.1 Company profile
7.10.2 Representative Biological Implants Product
7.10.3 Biological Implants Sales, Revenue, Price and Gross Margin of Baxter International, Inc.
7.11 Vericel Corporation
7.11.1 Company profile
7.11.2 Representative Biological Implants Product
7.11.3 Biological Implants Sales, Revenue, Price and Gross Margin of Vericel Corporation
7.12 Alphatec Spine, Inc
7.12.1 Company profile
7.12.2 Representative Biological Implants Product
7.12.3 Biological Implants Sales, Revenue, Price and Gross Margin of Alphatec Spine, Inc
7.13 CryoLife
7.13.1 Company profile
7.13.2 Representative Biological Implants Product
7.13.3 Biological Implants Sales, Revenue, Price and Gross Margin of CryoLife
7.14 Maxigen Biotech, Inc.
7.14.1 Company profile
7.14.2 Representative Biological Implants Product
7.14.3 Biological Implants Sales, Revenue, Price and Gross Margin of Maxigen Biotech, Inc.
7.15 IOP Ophthalmic Products, Inc.
7.15.1 Company profile
7.15.2 Representative Biological Implants Product
7.15.3 Biological Implants Sales, Revenue, Price and Gross Margin of IOP Ophthalmic Products, Inc.
7.16 CONMED
7.17 Allergan Plc
7.18 BioTissue
7.19 Auto Tissue Berlin GmbH
7.20 MiMedx Group, Inc.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOLOGICAL IMPLANTS
8.1 Industry Chain of Biological Implants
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOLOGICAL IMPLANTS
9.1 Cost Structure Analysis of Biological Implants
9.2 Raw Materials Cost Analysis of Biological Implants
9.3 Labor Cost Analysis of Biological Implants
9.4 Manufacturing Expenses Analysis of Biological Implants
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOLOGICAL IMPLANTS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
